Jim Simons Pds Biotechnology Corp Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 23,200 shares of PDSB stock, worth $37,584. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,200

Holding current value

$37,584

% of portfolio

0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.93 - $4.23 $67,976 - $98,136	23,200 New	23,200 $88,000
Q1 2024 May 13, 2024	BUY	$3.85 - $6.59 $901,285 - $1.54 Million	234,100 Added 193.95%	354,800 $1.41 Million
Q4 2023 Feb 13, 2024	BUY	$3.95 - $6.58 $476,765 - $794,206	120,700 New	120,700 $600,000
Q2 2023 Aug 11, 2023	SELL	$5.03 - $9.9 $1.72 Million - $3.39 Million	-342,875 Reduced 93.75%	22,862 $115,000
Q1 2023 May 12, 2023	BUY	$5.68 - $11.99 $672,512 - $1.42 Million	118,400 Added 47.87%	365,737 $2.25 Million
Q4 2022 Feb 13, 2023	SELL	$3.28 - $13.2 $245,957 - $989,828	-74,987 Reduced 23.26%	247,337 $3.27 Million
Q3 2022 Nov 14, 2022	SELL	$2.97 - $5.79 $204,077 - $397,848	-68,713 Reduced 17.57%	322,324 $957,000
Q2 2022 Aug 12, 2022	SELL	$3.05 - $6.68 $835,700 - $1.83 Million	-274,000 Reduced 41.2%	391,037 $1.43 Million
Q1 2022 May 13, 2022	BUY	$4.78 - $8.43 $1.05 Million - $1.86 Million	220,300 Added 49.53%	665,037 $4.12 Million
Q4 2021 Feb 11, 2022	BUY	$7.76 - $14.35 $612,264 - $1.13 Million	78,900 Added 21.57%	444,737 $3.6 Million
Q3 2021 Nov 12, 2021	SELL	$9.33 - $17.08 $836,154 - $1.53 Million	-89,620 Reduced 19.68%	365,837 $5.45 Million
Q2 2021 Aug 13, 2021	SELL	$4.35 - $12.86 $923,461 - $2.73 Million	-212,290 Reduced 31.79%	455,457 $5.72 Million
Q1 2021 May 13, 2021	SELL	$2.28 - $6.81 $367,020 - $1.1 Million	-160,974 Reduced 19.42%	667,747 $3.04 Million
Q4 2020 Feb 10, 2021	BUY	$1.91 - $2.67 $85,690 - $119,786	44,864 Added 5.72%	828,721 $1.77 Million
Q3 2020 Nov 13, 2020	BUY	$1.67 - $4.67 $269,178 - $752,733	161,185 Added 25.89%	783,857 $1.83 Million
Q2 2020 Aug 13, 2020	BUY	$0.65 - $2.6 $203,483 - $813,932	313,051 Added 101.11%	622,672 $1.25 Million
Q1 2020 May 14, 2020	BUY	$0.67 - $3.04 $126,865 - $575,630	189,352 Added 157.44%	309,621 $226,000
Q4 2019 Feb 13, 2020	BUY	$2.08 - $4.07 $59,696 - $116,809	28,700 Added 31.34%	120,269 $319,000
Q3 2019 Nov 13, 2019	BUY	$3.38 - $6.71 $44,278 - $87,901	13,100 Added 16.69%	91,569 $309,000
Q2 2019 Aug 12, 2019	BUY	$5.44 - $8.68 $207,291 - $330,751	38,105 Added 94.4%	78,469 $470,000
Q1 2019 May 14, 2019	BUY	$6.8 - $10.08 $274,475 - $406,869	40,364 New	40,364 $299,000

Others Institutions Holding PDSB

# of Institutions

Shares Held

4.05M

Call Options Held

253K

Put Options Held

70.4K

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $46.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account